An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance.

Expert Review of Gastroenterology & Hepatology
Rakesh SahuChandana Majee

Abstract

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease which on progression causes cirrhosis; various studies also suggested that several diseases can co-exist in patients. In existing depiction of disease PBC, apart from entire use of ursodeoxycholic acid (UDCA), several patients need to step forward to liver-transplantation or death due to resistance or non-responder with UDCA monotherapy. To overcome this non-respondent treatment, novel bile acid semi-synthetic analogs have been identified which shows their potency against for farnesoid X receptor and transmembrane G protein-coupled receptor-5 which are identified as target for many developing analogs which have desirable pharmacokinetic profiles. A range of studies suggests that adding semisynthetic analogs in therapeutic regime improves liver biochemistries in patients with suboptimal response to UDCA. Thus, the aspire of this review is to abridge and compare therapeutic value and current markets affirm of various bile acids semi-synthetic analogs which certainly are having promising effects in PBC monotherapy or in pooled treatment with UDCA for PBC.

References

Feb 1, 1991·The Journal of Veterinary Medical Science·T WashizuJ J Kaneko
Aug 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S M KramsM E Gershwin
Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P R GalleA Stiehl
Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A StiehlR Endele
Jan 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y CalmusR Poupon
Jun 29, 1989·The New England Journal of Medicine·B H MarkusT E Starzl
May 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S S LeeD Lebrec
Oct 1, 1972·Annals of Internal Medicine·G Klatskin, F S Kantor
Nov 21, 1996·The New England Journal of Medicine·M M Kaplan
May 21, 1999·Science·M MakishimaB Shan
Jun 9, 1999·Molecular Cell·H WangB M Forman
Dec 22, 1999·Archives of Internal Medicine·A F Hofmann
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·S FiorucciL J Ignarro
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·S FiorucciA Morelli
Aug 9, 2002·Journal of Medicinal Chemistry·Roberto PellicciariTimothy M Willson
Nov 7, 2002·Biochemical and Biophysical Research Communications·Takaharu MaruyamaKenichi Tanaka
Jan 14, 2003·The Journal of Biological Chemistry·Yuji KawamataMasahiko Fujino
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lia BellisJuan Rodés
Jan 23, 1958·The New England Journal of Medicine·I R MACKAY
Nov 5, 2003·Clinics in Liver Disease·Martin I Prince, Oliver F W James
Jun 5, 2004·Cardiovascular Drug Reviews·Stefano FiorucciAntonio Morelli
Jan 11, 2005·Current Vascular Pharmacology·Noemí M AtuchaJoaquín García-Estañ
Jan 13, 2005·Journal of Hepatology·Domenico AlvaroEugenio Gaudio
Aug 19, 2005·Journal of Medicinal Chemistry·Roberto PellicciariStefano Fiorucci
Dec 1, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alan F HofmannGeny M M Groothuis
Feb 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Takeshi InagakiSteven A Kliewer
Feb 24, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manuel Hernández-GuerraJaime Bosch
Mar 25, 2006·Nature Reviews. Drug Discovery·Larry MorelandPeter Kirkpatrick
Apr 11, 2006·Nuclear Receptor Signaling·Angie L Bookout, David J Mangelsdorf
Jun 3, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·Ulrich Beuers

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Y M LiX Ma
Clinics in Liver Disease
Frank Czul, Cynthia Levy
Expert Opinion on Pharmacotherapy
Ahmad H Ali, Keith D Lindor
Hepatology Research : the Official Journal of the Japan Society of Hepatology
Tadashi NamisakiHitoshi Yoshiji
© 2021 Meta ULC. All rights reserved